abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of LAR. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids LAR. Methods of using these compounds for modulation of LAR expression and for treatment of diseases associated with expression of LAR are provided. |